Literature DB >> 26798983

Ovarian reserve in women with Type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

C Kim1, R L Dunn2, B Braffett3, P A Cleary3, V Arends4, M Steffes4, M S M Lanham5, J F Randolph5, H Wessells6, M F Wellons7, A V Sarma2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26798983      PMCID： PMC4837044          DOI： 10.1111/dme.13072

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  6 in total

Review 1.  Premature Menopause.

Authors:  Saioa Torrealday; Lubna Pal
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06-22       Impact factor: 4.741

2.  Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Authors:  S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2011-05-25       Impact factor: 5.958

3.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

4.  Development of a second generation anti-Müllerian hormone (AMH) ELISA.

Authors:  Ajay Kumar; Bhanu Kalra; Amita Patel; Lauren McDavid; William E Roudebush
Journal:  J Immunol Methods       Date:  2010-08-27       Impact factor: 2.303

5.  Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus.

Authors:  Néstor Soto; Germán Iñiguez; Patricia López; Gladys Larenas; Verónica Mujica; Rodolfo A Rey; Ethel Codner
Journal:  Hum Reprod       Date:  2009-07-30       Impact factor: 6.918

6.  Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?

Authors:  Tito Silvio Patrelli; Salvatore Gizzo; Nicoletta Sianesi; Luca Levati; Antonio Pezzuto; Bruno Ferrari; Alberto Bacchi Modena
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240
  6 in total
  3 in total

Review 1.  Ovarian aging in women with diabetes: An overview.

Authors:  Melissa F Wellons; Juliana J Matthews; Catherine Kim
Journal:  Maturitas       Date:  2016-12-02       Impact factor: 4.342

2.  Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study.

Authors:  Catherine Kim; Carrie Karvonen-Gutierrez; Shengchun Kong; Valerie Arends; Michael Steffes; Daniel S McConnell; John F Randolph; Siobán D Harlow
Journal:  Fertil Steril       Date:  2016-07-28       Impact factor: 7.329

3.  Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes.

Authors:  Catherine Kim; Yuanyuan Pan; Barbara H Braffett; Valerie L Arends; Michael W Steffes; Hunter Wessells; Aruna V Sarma
Journal:  Womens Midlife Health       Date:  2017-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.